EDGAR Filing Documents for 0001396814-15-000013

Form 8-K - Current report:

SEC Accession No. 0001396814-15-000013

Filing Date

2015-10-27

Accepted

2015-10-27 07:40:18

Documents

Period of Report

2015-10-27

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	PCRX 8-K Q3 2015	pcrx8-kq32015.htm	8-K	22356
2	EXHIBIT 99.1	pcrx991q32015.htm	EX-99.1	265661
3		pacirapharmaceuticals_image1.gif	GRAPHIC	3880
	Complete submission text file	0001396814-15-000013.txt		293937

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 151176221
SIC: 2834 Pharmaceutical Preparations